RIG-I has guts: identification of a role for RIG-I in colitis development.

RIG-I has guts: identification of a role for RIG-I in colitis development. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

RIG-I has guts: identification of a role for RIG-I in colitis development. Abstract Text:

Mayra Solis,Delphine Goubau,John Hiscott,Mayra Solis,Delphine Goubau,John Hiscott,

RIG-I has guts: identification of a role for RIG-I in colitis development. Publishing Authors By Initials

M Solis,D Goubau,J Hiscott,M Solis,D Goubau,J Hiscott,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

RIG-I has guts: identification of a role for RIG-I in colitis development. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cell research

VOLUME: 17

Page Numbers: 974-5

Journal Abbreviation: Cell Res.

ISSN: 1748-7838

DAY: 13

MONTH: Dec

YEAR: 2007

RIG-I has guts: identification of a role for RIG-I in colitis development. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9425763

RIG-I has guts: identification of a role for RIG-I in colitis development. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: RIG-I has guts: identification of a role for RIG-I in colitis development. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for RIG-I has guts: identification of a role for RIG-I in colitis development.

AFFILIATION: Lady Davis Institute for Medical Research - Jewish General Hospital, Department of Microbiology & Immunology, McGill University, Montreal, Canada.

Country: China

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cell Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

RIG-I has guts: identification of a role for RIG-I in colitis development Related Publications

• Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis.
• Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response.
• Cytokeratin subtyping to distinguish reactive and neoplastic RPE cells.
• Health services in four isolated districts in Nova Scotia.
• Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin).
• Human papillomavirus in pterygium.
• Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20.
• Neoplastic transformation of ciliary body epithelium is associated with loss of opticin expression.
• RIG-I has guts: identification of a role for RIG-I in colitis development.
• SDF1-alpha is associated with VEGFR-2 in human choroidal neovascularisation.
• Targeting the apoptotic pathway with BCL-2 inhibitors sensitizes primary chronic lymphocytic leukemia cells to vesicular stomatitis virus-induced oncolysis.
• Temporal pterygium: benign or not?
• Ub Surprised: Viral Ovarian Tumor Domain Proteases Remove Ubiquitin and ISG15 Conjugates.
• Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation.